# Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma

> **NCT00257816** · PHASE2 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 12 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Topotecan
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00257816
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2007-12-17
- **Final completion:** 2007-12-17
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00257816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00257816, "Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00257816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*